ResMed (RMD) Appoints Desney Tan and John Hernandez to Its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors
November 19, 2021 9:00 AM ESTTan is vice president and managing director of Microsofts Health and Life Science R&D Hernandez is Googles head of clinical research, health economics, and outcomes researchBoth leaders digital health experience at world-leading tech firms can help oversee ResMeds strategy to improve 250 million lives in 2025ResMeds board increases from eight to ten directors
SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX:... More
